Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy

BACKGROUND: Patients with metastatic urothelial carcinoma (mUC) have an uncertain prognosis. The aim of the current study was to evaluate the prognostic potential of a skeletal muscle mass reduction index measured by computed tomography (CT) for mUC patients undergoing second-line gemcitabine and do...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Takashi, Naiki, Taku, Iida, Keitaro, Nozaki, Satoshi, Etani, Toshiki, Sugiyama, Yosuke, Ando, Ryosuke, Yanase, Takahiro, Chaya, Ryosuke, Moritoki, Yoshinobu, Kobayashi, Daichi, Akita, Hidetoshi, Okamura, Takehiko, Yasui, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982681/
https://www.ncbi.nlm.nih.gov/pubmed/31653146
http://dx.doi.org/10.31557/APJCP.2019.20.10.2995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982681/
https://www.ncbi.nlm.nih.gov/pubmed/31653146
http://dx.doi.org/10.31557/APJCP.2019.20.10.2995

Ejemplares similares